Global Lice Treatment Market 2022-2026
Technavio has been monitoring the lice treatment market and it is poised to grow by $ 128.97 mn during 2022-2026, progressing at a CAGR of 6.26% during the forecast period. Our report on the lice treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of lice infestation, rising healthcare expenditure, and easy availability of lice treatment products. In addition, the increasing prevalence of lice infestation is anticipated to boost the growth of the market as well.
The lice treatment market analysis includes the distribution channel segment and geographic landscape.
Technavio's lice treatment market is segmented as below:
By Distribution Channel
- Hospitals and clinics
- Online
- Retail pharmacies
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the growing population of children as one of the prime reasons driving the lice treatment market growth during the next few years. Also, rising investments for R&D in targeted therapies and the emergence of novel treatment options will lead to sizable demand in the market.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on lice treatment market covers the following areas:
- Lice treatment market sizing
- Lice treatment market forecast
- Lice treatment market industry analysis
Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading lice treatment market vendors that include Alliance Pharma Plc, American Vanguard Corp., Arbor Pharmaceuticals LLC, Elanco Animal Health Inc., Fleming Medical Ltd., Johnson and Johnson Inc., Logic Product Group LLC, Marico Ltd., Merck and Co. Inc., Nix Pharma Pvt Ltd., PARAPRO LLC, Perrigo Co. Plc, Prestige Consumer Healthcare Inc., SHIONOGI Co. Ltd., TecLabs Inc., Teva Pharmaceutical Industries Ltd., Thornton & Ross Ltd., and Bayer AG. Also, the lice treatment market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.